AUTUMN WHITTEN: Open Payments
NPI 1740877745 · PORT HURON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 20 payments from 13 companies in 2025. Trend: 2023 $619 · 2024 $356 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $71 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Amgen Inc. | 3 | $45 |
| Novo Nordisk Inc | 2 | $35 |
| Corcept Therapeutics | 1 | $25 |
| Hologic Sales and Service, LLC | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $18 |
Products named: Auvelity, FANAPT, REXULTI, OTEZLA, Korlym, THINPREP 2000 PROCESSOR, CAPLYTA, VPRIV.
Industry payments across MI — which companies pay providers there.
